Investors
Information Disclosure
-
FORM OF PROXY FOR USE AT THE ANNUAL GENERAL MEETING (OR ANY ADJOURNMENT OR POSTPONEMENT THEREOF)2025.04.29
-
NOTIFICATION LETTER AND REPLY FORM FOR REGISTERED SHAREHOLDERS2025.04.29
-
NOTIFICATION LETTER AND REQUEST FORM FOR NON-REGISTERED SHAREHOLDERS2025.04.29
-
2024 ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT2025.04.29
-
VOLUNTARY ANNOUNCEMENT - APPROVAL FOR MARKETING OF PENPULIMAB INJECTION BY THE US FDA2025.04.25
-
VOLUNTARY ANNOUNCEMENT - 45 RESEARCH RESULTS WILL BE PRESENTED AT 2025 ASCO ANNUAL MEETING (INCLUDING 12 ORAL SESSIONS)2025.04.24
-
ADOPTION OF THE NEW ARTICLES2025.04.23
-
NEXT DAY DISCLOSURE RETURN2025.04.09